5-Bromo-2-tert-butylpyrimidine, 95.0%, 500mg

[(6-fluoropyridin-3-yl)methyl](methyl)amine dihydrochloride, 1g

5-Benzyl-1,3,4-oxadiazol-2-yl hydrosulfide, 95.0%, 250mg

(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol, 95.0%, 10g

4-Fluoro-3,5-dimethylphenyl methyl sulfide, 97.0%, 1g

3-(3-Methoxyphenyl)-5-[(4-methoxyphenyl)methylidene]-2-sulfanylideneimidazolidin-4-one, 95%, 100mg

(E)-3-(4-(N-(furan-2-ylmethyl)sulfamoyl)phenyl)acrylic acid, 98%, 100mg

2-(5,6-Dihydro-2H-pyran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 94.0%, 1g

(R)?-5,?5',?6,?6',?7,?7',?8,?8'-Octahydro-?3,?3'-?bis(2,?4,?6-?trimethylphenyl)?-[1,?1'-?binaphthalene]?-?2,?2'-?diol, 97%, 100mg

2-[(4-tert-butylphenyl)formamido]-3-methylbutanoic acid, 97%, 500mg

Fmoc-Asp-OMe, 95%, 10g

Dichlorodicyclopentylsilane, 98%, 10g

Benzyl 1,9-diazaspiro[5.5]undecane-9-carboxylate, 97%, 250mg